Krystal Eckhart's departure as Chief Executive Officer of Selectis Health, Inc. was reported; the filing names no successor. As of November 6, 2026, Selectis Health, Inc. has reported 4 leadership change filings to the SEC under Item 5.02 of Form 8-K, from March 31, 2026 to October 9, 2026, naming 1 appointment and 1 departure (Form 8-K, September 9, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Selectis Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-10-09
- · In / out: Out · Person: Krystal Eckhart · Role: Chief Executive Officer · 8-K, 2026-09-09
- · In / out: In · Person: Krystal Eckhart · 8-K, 2026-05-20
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-03-31
Selectis Health, Inc. reported changes in 4 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-31 to 2026-10-09. They name 1 person, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Selectis Health, Inc. files it.
Also on the record for Selectis Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 5, 2026 | Acquired by Black Pearl Equities, LLC | $17.64M | Acquisition | Source |
Selling to them or working with them? See who runs Selectis Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Selectis Health, Inc. and the records around it.
Selectis Health, Inc. elsewhere on the record
- Acquisition Oct 2026
Watch Selectis Health, Inc.
Get an email when Selectis Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Selectis Health, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Selectis Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Selectis Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-09 | Reported | not named in the filing | 8-K, 2026-10-09 | ||
| 2026-09-09 | Out | Chief Executive Officer | 8-K, 2026-09-09 | ||
| 2026-05-20 | In | 8-K, 2026-05-20 | |||
| 2026-03-31 | Reported | not named in the filing | 8-K, 2026-03-31 |
Who leads Selectis Health, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Krystal Eckhart, departure reported (filed 2026-09-09). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Selectis Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Selectis Health, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Selectis Health, Inc.Every change, in the filing's words
Reported
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the "Board") and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
- These departures were in connection with the Merger and were not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, Abraham Schwartz and Zalman Schapiro, being the directors of Merger Sub immediately prior to the Effective Time, became the directors of the Company, and Abraham Schwartz and Zalman Schapiro, being the officers of Merger Sub immediately prior to the Effective Time, became the officers of the Company.
Departing: Krystal Eckhart, Chief Executive Officer
Neither Mr. Schwartz nor Mr. Schapiro has been appointed to any committee of the Board as of the date of this Current Report on Form 8-K.Other than as described above and in the Merger Agreement, neither Mr. Schwartz nor Mr. Schapiro has any interest, direct or indirect, in any transaction, or any currently proposed transaction, required to be disclosed pursuant to Item 404(a)of Regulation S-K. On September 1, 2026, Krystal Eckhart resigned as Interim Chief Executive Officer of the Company, effective immediately.
- On September 1, 2026, Lance J. Baller resigned as a member of the Company's Board of Directors (the "Board"), and from all committees of the Board on which he served, effective immediately.
- The resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. 3 On September 1, 2026, Abraham Schwartz and Zalman Schapiro were appointed as directors of the Company effective as of September 1, 2026.
- Messrs. Schwartz and Schapiro were designated for election to the Board by Parent in connection with the tender offer by Merger Sub for shares of the Company's common stock, made pursuant to the Agreement and Plan of Merger, dated as of June 22, 2026, by and among the Company, Parent, Black Pearl Equities II, LLC and Merger Sub.
- Mr. Schwartz serves as Chief Executive Officer of Parent and Mr. Schapiro is a principal of Parent.
- Ms. Eckhart's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- Ms. Eckhart continues to serve as the Company's Interim Chief Financial Officer and principal financial officer.
Appointed: Krystal Eckhart
On May 15, 2026, the Board of Directors of the Company appointed Krystal Eckhart to serve as the Company's Interim CEO and CFO.
- DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS Effective May 14, 2026 the Board of Directors of Selectis Health, Inc., a Utah corporation (the "Company") and Adam Desmond ("Desmond") agreed that he would resign all positions with the Company including CEO, CFO of the Company and a member of the Board of Directors.
- Ms. Eckhart currently serves as a Vice President of the Company.
- Below is the biographical information for Ms. Eckhart.
- Krystal Eckhart, age 41, is an accomplished healthcare revenue cycle and financial operations leader with 15+ years of progressive management experience across skilled nursing facilities and multi-state healthcare organizations.
- Ms. Eckhart has worked with the Company in various capacities since 2016.
- Currently she serves as a Vice President of Revenue Management, specializing in Lead Medicare and Medicaid operations for 9 multi-state healthcare facilities; overseeing SEC audits, financial reporting, AR/AP operations, and acquisition-related financial processes.
- She also manages corporate and facility-level employees through training, performance oversight, and operational support.
Reported
DEPARTURE OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER On March 30, 2026, David Furstenberg submitted his letter of resignation as a member of the Board of Directors and Audit Committee of Selectis Health, Inc., a Utah corporation (the "Company"), effective immediately.
- The Company would like to thank Mr. Furstenberg for his generous service and support.
Tools for this story
Each opens in a new tab, filled in for Selectis Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.